SADA:LSE:LSE-Amundi Index Solutions - Amundi Index MSCI EM Asia SRI PAB UCITS ETF DR USD (D) (USD)

ETF | Others |

Last Closing

USD 40.09

Change

+0.98 (+2.49)%

Market Cap

USD 0.13B

Volume

108.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+2.25 (+1.22%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+2.13 (+1.83%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.41%)

USD 572.76B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.09 (-0.47%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.45 (-2.01%)

USD 266.08B
0QZO:LSE 0QZO

+0.45 (+0.48%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.15 (-0.48%)

USD 208.06B
0QZ3:LSE Qualcomm Inc.

+0.57 (+0.34%)

USD 202.26B
0R24:LSE Intel Corp.

+0.26 (+1.15%)

USD 196.14B

ETFs Containing SADA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.52% 79% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.52% 78% C+ 75% C
Trailing 12 Months  
Capital Gain 20.25% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.25% 57% F 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.58% N/A N/A 25% F
Dividend Return -3.58% N/A N/A 25% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.48% N/A N/A 92% A
Risk Adjusted Return -65.30% N/A N/A 11% F
Market Capitalization 0.13B 53% F 30% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike